iPS-derived cardiomyocytes

“In what is a world-first and potentially the dawn of a new medical technology to treat damaged hearts, scientists in Japan have succeeded in transplanting lab-grown heart cells into a human patient for the first time ever. The procedure is part of a cutting-edge clinical trial hoped to open up new avenues in regenerative medicine, with the treatment to be given to a further nine patients over the coming years.”  The technique involves growing IPSCs on sheets, which a surgeon lays on a damaged heart.  Over time, the sheet material dissolves and the cells continue to grow.      MORE

Image Credit:  Flickr